Attività di ricerca
Ultime pubblicazioni:
-
Calabrò, L., P Caruso, F., Covre, A., R Noviello, T.M., F Lofiego, M., Tufano, R., et al. (2026). Tumor DNA methylation subtypes predict immunotherapy outcomes in pleural mesothelioma patients in the NIBIT-EPI-MESO study. NATURE GENETICS, 58(5), 1100-1111 [10.1038/s41588-026-02580-4]. - dettaglio
-
Marabelle, A., O’Malley, D.M., Hendifar, A.E., Ascierto, P.A., Motola-Kuba, D., Penel, N., et al. (2025). Pembrolizumab in microsatellite-instability-high and mismatch-repair-deficient advanced solid tumors: updated results of the KEYNOTE-158 trial. NATURE CANCER. - dettaglio
-
Lofiego, M.F., Tufano, R., Bello, E., Solmonese, L., Marzani, F., Piazzini, F., et al. (2025). Abstract 4841: DNA methylation status classifies pleural mesothelioma cells according to their immune profile: implication for precision epigenetic therapy. In Cancer Research (pp.4841-4841) [10.1158/1538-7445.am2025-4841]. - dettaglio
-
Anichini, A., Caruso, F.P., Lagano, V., Noviello, T.M.R., Tufano, R., Nicolini, G., et al. (2025). Integrated multi-omics profiling reveals the role of the DNA methylation landscape in shaping biological heterogeneity and clinical behaviour of metastatic melanoma. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 44(1) [10.1186/s13046-025-03474-9]. - dettaglio
-
Di Giacomo, A.M., Canetta, R., Connolly, J., Leidner, R., Zheng, W., Kim, Y., et al. (2025). Approaches to overcome the current treatment plateau in immunotherapy. EUROPEAN JOURNAL OF CANCER, 226 [10.1016/j.ejca.2025.115605]. - dettaglio
